Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early ...

US FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system: Galway, Ireland Monday, April 21, 2025, ...

AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration ...

A panelist discusses how autoimmune screening through detection of diabetes-specific autoantibodies serves as a critical tool for identifying pre-symptomatic type 1 diabetes (T1D), enabling earlier ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

Medtronic plc has announced the U.S. Food and Drug Administration (FDA) has approved the Simplera Sync sensor for use with ...

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations.

While Type 5 diabetes remains a concept rather than a defined clinical entity the underlying message is clear effectively ...

Diabetes has emerged as one of the most pressing public health concerns in India. As per the International Diabetes ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...